A nanobody-derived mimotope against VEGF inhibits cancer angiogenesis
Vascular Endothelial Growth Factor (VEGF) promotes angiogenesis in tumours of various cancers. Monoclonal antibodies and nanobodies are one of the potent agents in the treatment of cancer. Due to their high costs, researchers are considering to design and produce peptides as a substitute approach in...
Shranjeno v:
| Principais autores: | , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Taylor & Francis Group
2020-01-01
|
| Serija: | Journal of Enzyme Inhibition and Medicinal Chemistry |
| Teme: | |
| Online dostop: | http://dx.doi.org/10.1080/14756366.2020.1758690 |
| Oznake: |
Brez oznak, prvi označite!
|